North American prazosin market is estimated to decline at a CAGR of around -1.9% during the forecast period. Moreover, the discontinuation of prazosin drug manufacturing by various companies also showcases the low opportunity in the market. In the US, Pfizer has discontinued Minipress XL, Minizide, and only marketing Minipress. Other companies including Watson Labs, Ani Pharms Inc., Dava Pharms Inc., Purepac Pharm has already discontinued the manufacturing of prazosin hydrochloride in the US market. Lower sales of the branded drug are also restraining the growth of the market. As per ClinCalc LLC (an online medical resource tool website), the prescription of prazosin in the US was increased to 2.4 million in 2016 from around 1.0 million in 2014. After 2016, the number of prescriptions of prazosin is expected to decrease continuously in the near future.
Get Free Sample link @ https://www.omrglobal.com/request-sample/north-american-prazosin-market
The North American prazosin market is segmented on the basis of application. Based on the application, the market is segmented into cardiovascular disease, neurological syndromes, prostate disorders, and kidney disorders. The CVD segment accounted for the significant share in the North American prazosin market. CVDs claim to take more lives each year than all forms of cancer and chronic lower respiratory diseases altogether. Thus, Prazosin is one of the treatments used for CVD mainly high BP and strokes. For instance, Minipress is specified for the treatment of hypertension, to control BP. Lowering blood pressure decreases the risk of fatal and nonfatal cardiovascular events, mainly strokes and myocardial infarction.
A full report of North American Prazosin Market available @ https://www.omrglobal.com/industry-reports/north-american-prazosin-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
North American Prazosin Market by Application
- Cardiovascular Disease(CVD)
- Neurological Syndromes
- Prostate Disorders
- Kidney Disorders
Regional Analysis
- US
- Canada
Company Profiles
- Apotex Inc.
- Axon Medchem LLC
- Cayman Chemical Co.
- Merck KGaA
- NovitiumPharma
- Pfizer Inc.
- R&D Systems Inc.
- Mylan N.V.
- Teva Pharmaceuticals Industries Ltd.
- TRC Inc.
The Report Covers
- Comprehensive research methodology of the North American prazosin market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the North American prazosin market.
- Insights about market determinants which are stimulating the North American prazosin market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-prazosin-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
